CUMYL-PICA

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
CUMYL-PICA
CUMYL-PICA structure.png
Systematic (IUPAC) name
1-pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide
Clinical data
Legal status
Identifiers
CAS Number 1400742-32-6
PubChem CID: 86273678
ChemSpider 34450887
Chemical data
Formula C23H28N2O
Molecular mass 348.49 g/mol
  • O=C(NC(C)(C)C1=CC=CC=C1)C2=CN(CCCCC)C3=C2C=CC=C3
  • InChI=1S/C23H28N2O/c1-4-5-11-16-25-17-20(19-14-9-10-15-21(19)25)22(26)24-23(2,3)18-12-7-6-8-13-18/h6-10,12-15,17H,4-5,11,16H2,1-3H3,(H,24,26)
  • Key:RCXFMWJQOYCIQU-UHFFFAOYSA-N

CUMYL-PICA (SGT-56) is an indole-3-carboxamide based synthetic cannabinoid. It is the α,α-dimethylbenzyl analogue of SDB-006.[1] It was briefly sold in New Zealand during 2013 as an ingredient of at the time legal synthetic cannabis products, but the product containing CUMYL-BICA and CUMYL-PICA was denied an interim licensing approval under the Psychoactive Substances regulatory scheme, due to reports of adverse events in consumers.[2] CUMYL-PICA acts as a potent agonist for the cannabinoid receptors, with approximately 20x selectivity for CB1, having an EC50 of 0.66nM for human CB1 receptors and 13nM for human CB2 receptors.[3]

See also

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. The Risk Assessment Score Table. New Zealand Ministry of Health, 27 September 2013
  3. Lua error in package.lua at line 80: module 'strict' not found.

<templatestyles src="Asbox/styles.css"></templatestyles>